TREATMENTS INVOLVING ESLICARBAZEPINE ACETATE OR ESLICARBAZEPINE
First Claim
Patent Images
1. A method of treating partial-onset seizures in a patient who is suffering from or susceptible to absence seizures, which method comprises:
- administering to said patient a safe and effective amount of eslicarbazepine acetate.
2 Assignments
0 Petitions
Accused Products
Abstract
The invention provides a drug selected from eslicarbazepine acetate and eslicarbazepine, for use in treating or preventing a disorder selected from epilepsy, affective disorders, schizoaffective disorders, bipolar disorders, neuropathic pain and neuropathic pain related disorders, attention disorders, anxiety disorders, sensorimotor disorders, vestibular disorders, and fibromyalgia, in a patient suffering from or susceptible to absence seizures.
0 Citations
34 Claims
-
1. A method of treating partial-onset seizures in a patient who is suffering from or susceptible to absence seizures, which method comprises:
administering to said patient a safe and effective amount of eslicarbazepine acetate. - View Dependent Claims (5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 31)
-
2-4. -4. (canceled)
-
18. A method of treating partial-onset seizures in a patient who is suffering, from or susceptible to absence seizures, which method comprises:
administering to said patient a safe and effective amount of a pharmaceutical composition, which comprises a pharmaceutically acceptable carrier and a safe and effective amount of eslicarbazepine acetate as an active ingredient. - View Dependent Claims (19)
-
20-23. -23. (canceled)
-
24. A method of treating partial onset seizures, which method comprises:
-
(a) selecting a patient who is suffering from or susceptible to absence seizures; and (b) administering to said patient a safe and effective amount of eslicarbazepine acetate, or a pharmaceutical composition, which comprises a pharmaceutically acceptable carrier and a safe and effective amount of eslicarbazepine acetate as an active ingredient.
-
-
25-29. -29. (canceled)
-
30. A method of reducing the incidence of absence seizures in a patient, which method comprises administering to said patient a safe and effective amount of eslicarbazepine acetate, or a pharmaceutical composition, which comprises a pharmaceutically acceptable carrier and a safe and effective amount of eslicarbazepine acetate as an active ingredient.
-
32. A pharmaceutical composition for treating partial-onset seizures in patients that are suffering from or susceptible to absence seizures, said composition comprising eslicarbazepine acetate and a pharmaceutically acceptable carrier.
-
33. Eslicarbazepine acetate for use in treating partial-onset seizures in patients that are suffering from or susceptible to absence seizures.
-
34. Use of eslicarbazepine acetate for treating partial-onset seizures in patients that are suffering from or susceptible to absence seizures.
Specification